Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions

Respiratory Medicine

Volumn 102, Issue 5, 2008, Pages 774-779

  Economidou, Foteini ^a   Antoniou, Katerina M ^a   Tzanakis, Nikolaos ^b   Sfiridaki, Katerina ^c   Siafakas, Nikolaos M ^a   Schiza, Sofia E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c Venizelion General Hospital   (Greece)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Exudates; Receptor tyrosine kinase Tie 2; Transudates; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; RECEPTOR, TIE-2; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41149153223     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.10.021     Document Type: Article

References (36)

1. Brown L.F., Detmar M., Claffey K., et al. Vascular permeability factor/vascular endothelial growth factors: a multifunctional angiogenic cytokine. EXS 79 (1997) 233-269
2. Antony V.B. Immunological mechanisms in pleural disease. Eur Respir J 21 (2003) 539-544
3. McDonald D.M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164 (2001) S39-S45
4. Hoshino M., Takahashi M., and Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107 (2001) 295-301
5. Hoshino M., Nakamura Y., and Hamid Q.A. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107 (2001) 1034-1038
6. Sack U., Hoffmann M., Zhao X.J., et al. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 25 (2005) 600-604
7. Ruiz E., Aleman C., Alegre J., et al. Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions. Lung 183 (2005) 185-195
8. Cheng D., Rodriguez R.M., Perkett E.A., et al. Vascular endothelial growth factor in pleural fluid. Chest 116 (1999) 760-765
9. Grove C.S., and Lee Y.C.G. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 8 (2002) 294-301
10. Yancopoulos G.D., Davis S., Gale N.W., et al. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
11. Ferrara N., Carver-Moore K., Chen H., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
12. Cheng D., Lee Y.C.G., Rogers J.T., et al. Vascular endothelial growth factor level correlates with transforming growth factor-ß isoform levels in pleural effusions. Chest 118 (2000) 1747-1753
13. Hamed E.A., El-Noweihi A.M., Mohamed A.Z., et al. Vasoactive mediators (VEGF and TNF-α) in patients with malignant and tuberculous pleural effusions. Respirology 9 (2004) 81-86
14. Momi H., Matsuyama W., Inoue K., et al. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med 96 (2002) 817-822
15. Yanagawa H., Takeuchi E., Suzuki Y., et al. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer. Cancer Immunol Immunother 48 (1999) 396-400
16. Zebrowski B.K., Yano S., Liu W., et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 5 (1999) 3364-3368
17. Kalomenidis I., Kollintza A., Sigala I., et al. Angiopoietin-2 levels are elevated in exudative pleural effusions. Chest 129 (2006) 1259-1266
18. Lim S.C., Jung S.I., Kim Y.C., and Park K.O. Vascular endothelial growth factor in malignant and tuberculous pleural effusions. J Korean Med Sci 15 (2000) 279-283
19. Ishimoto O., Saijo Y., Narumi K., et al. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer. Oncology 63 (2002) 70-75
20. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
21. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
22. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
23. Holash J., Maisonpierre P.C., Compton D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
24. Teichert-Kuliszewska K., Maisonpierre P.C., Jones N., et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49 (2001) 659-670
25. Light W.R., MacGregor M.I., Luchsinger P.C., et al. Pleural effusions: the diagnostic separation of transudations and exudates. Ann Intern Med 77 (1972) 507-514
26. Light RW. Physiology of the pleural space. In: Pleural diseases, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 8-20 [chapter 2].
27. Light RW. Clinical manifestations and useful tests. In: Pleural diseases, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 42-86 [chapter 4].
28. Clifford C.A., Hughes D., Beal M.W., et al. Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. J Vet Intern Med 15 (2001) 131-135
29. Davis S., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
30. Takahama M., Tsutsumi M., Tsujiuchi T., et al. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. Clin Cancer Res 5 (1999) 2506-2510
31. Wong M.P., Chan S.Y., Fu K.H., et al. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. Lung Cancer 29 (2000) 11-22
32. Takanami I. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Oncol Rep 12 (2004) 849-853
33. Peters K.G., Coogan A., Berry D., et al. Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis. Br J Cancer 77 (1998) 51-55
34. Zhang Z.L., Liu Z.S., and Sun Q. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Gastroenterol 12 (2006) 4241-4245
35. Chang H., Wang B.W., Kuan P., et al. Cyclical mechanical stretch enhances angiopoietin-2 and Tie2 receptor expression in cultured human umbilical vein endothelial cells. Clin Sci 104 (2003) 421-428
36. Konstantinovsky S., Nielsen S., Vyberg B., et al. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Breast Cancer Res Treat 94 (2005) 71-80